Abstract
AbstractBackgroundThe development of diverse spatial profiling technologies has provided an unprecedented insight into molecular mechanisms driving cancer pathogenesis. Here, we conducted the first integrated cross-species assessment of spatial transcriptomics and spatial metabolomics alterations associated with progression of intraductal papillary mucinous neoplasms (IPMN),bona fidecystic precursors of pancreatic ductal adenocarcinoma (PDAC).MethodsMatrix Assisted Laster Desorption/Ionization (MALDI) mass spectrometry (MS)-based spatial imaging and Visium spatial transcriptomics (ST) (10X Genomics) was performed on human resected IPMN tissues (N= 23) as well as pancreata from a mutantKras;Gnasmouse model of IPMN. Findings were further compared with lipidomic analyses of cystic fluid from 89 patients with histologically confirmed IPMNs, as well as single-cell and bulk transcriptomic data of PDAC and normal tissues.ResultsMALDI-MS analyses of IPMN tissues revealed long-chain hydroxylated sulfatides, particularly the C24:0(OH) and C24:1(OH) species, to be selectively enriched in the IPMN and PDAC neoplastic epithelium. Integrated ST analyses confirmed that the cognate transcripts engaged in sulfatide biosynthesis, includingUGT8, Gal3St1, andFA2H, were co-localized with areas of sulfatide enrichment. Lipidomic analyses of cystic fluid identified several sulfatide species, including the C24:0(OH) and C24:1(OH) species, to be significantly elevated in patients with IPMN/PDAC compared to those with low-grade IPMN. Targeting of sulfatide metabolism via the selective galactosylceramide synthase inhibitor, UGT8-IN-1, resulted in ceramide-induced lethal mitophagy and subsequent cancer cell deathin vitro, and attenuated tumor growth of mutantKras;Gnasallografts. Transcript levels ofUGT8andFA2Hwere also selectively enriched in PDAC transcriptomic datasets compared to non-cancerous areas, and elevated tumoralUGT8was prognostic for poor overall survival.ConclusionEnhanced sulfatide metabolism is an early metabolic alteration in cystic pre-cancerous lesions of the pancreas that persists through invasive neoplasia. Targeting sulfatide biosynthesis might represent an actionable vulnerability for cancer interception.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. Prevalence of Unsuspected Pancreatic Cysts on MDCT
2. The incidental pancreatic cyst;Radiologic clinics of North America,2011
3. Pancreatic cystic tumours: when to resect, when to observe;European review for medical and pharmacological sciences,2010
4. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics;Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2010
5. Genomic characterization of malignant progression in neoplastic pancreatic cysts